Descartes (DSGX) PT Lowered to $130 at RBC Capital

RBC Capital analyst Paul Treiber lowered the price target on Descartes (NASDAQ: DSGX) to $130.00 (from $133.00) while maintaining a Outperform rating.

The analyst commented: "Organic growth lighter than expected, but Descartes is likely to chug along regardless; Despite the tailwind from increased demand for Descartes' Global Trade Intelligence subscriptions, Q4 revenue and Q1 baseline were lighter than expected. Although we're slightly reducing our financial estimates, we believe tariff uncertainty will be a long-term driver of increased uptake of supply chain management software. Moreover, the M&A environment remains favourable and we see additional acquisitions as potential catalysts for the stock. Maintain Outperform, target to $130."

You May Also Be Interested In

• Moderna (MRNA) PT Raised to $89 at Morgan Stanley
• KeyBanc Upgrades EPR Properties (EPR) to Overweight
• JPMorgan Reiterates Overweight Rating on Marvell (MRVL)